Sponsor

Excellthera Inc.

Marcelle-Coutu Pavilion, 2950 Chemin De Polytechnique, H3T 1J4

About the sponsor

Excellthera Inc. focuses on acute leukemia and myelodysplasia in patients with high-risk and very high-risk disease profiles, with particular attention to cases requiring allogeneic haematopoietic stem cell transplantation.

High-risk acute leukemia
Very high-risk acute leukemia
Myelodysplasia

The therapeutic interest is centered on transplant-supported treatment pathways for advanced blood cancers.

About Specializations

Excellthera Inc. runs clinical trials in conditions such as Allogenic stem cell transplantation, among others.

Allogenic stem cell transplantation

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Allogenic stem cell transplantation

Not yet recruiting

Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

InvestigationalNo placebo

Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

InvestigationalNo placebo

The Netherlands

Participants:18–64 years
Substances:Dorocubicel
Sponsor:Excellthera Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

About Specializations

Ongoing trials

1 clinical trial

Allogenic stem cell transplantation

Study of UM171-expanded cord blood transplantation for patients with high-risk and very high-risk acute leukemia or myelodysplasia

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.